MALAT1 and lung carcinoma: Again one of them is MALAT1, which has been shown to be an active player in lung cancer metastasis, and targeting MALAT1 by ASO drastically reduced metastasis formation of this tumor cells in vivo, suggesting the use of an ASO against lncRNA in lung cancer therapy [140].